Developments of combretastatin A-4 derivatives as anticancer agents

Current Medicinal Chemistry

Volumn 18, Issue 4, 2011, Pages 523-538

  Shan, Y ^a   Zhang, J ^a   Liu, Z ^b   Wang, M ^a   Dong, Y ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Anticancer; Antineoplastic agents; Combretastatin A 4; Structure activity relationships; Tubulin inhibitors

Indexed keywords

COMBRETASTATIN A4;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BURKITT LYMPHOMA; CHEMICAL BOND; CHEMICAL MODIFICATION; COLORECTAL CANCER; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; HUMAN; IC 50; LUNG NON SMALL CELL CANCER; MICROTUBULE ASSEMBLY; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PROSTATE CANCER; STOMACH SARCOMA; THYROID CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; COMBRETUM; HUMANS; NEOPLASMS; STILBENES; TUBULIN; TUBULIN MODULATORS;

EID: 79851496869     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794480221     Document Type: Article

References (72)

1. Jordan, M. A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 2004, 4(4), 253-265. (Pubitemid 38525281)
2. Holt, H.; LeBlank, R.; Dickson, J.; Brown, T.; Maddox, J. R.; Lee, M. Reaction of chalcones with basic hydrogen peroxide: A structure and reactivity study. Top. Heterocycl. Chem., 2006, 11(6), 465-470. (Pubitemid 43097841)
3. Lin, C. M.; Singh, S. B.; Chu, P. S.; Dempcy, R. O.; Schmidt, J. M.; Pettit, G. R.; Hamel, E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol. Pharmacol., 1988, 34(2), 200-208.
4. Kingston, D. G. I. Tubulin-interactive natural products as anticancer agents. J. Nat. Prod., 2009, 72(3), 507-515.
5. Ohsumi, K.; Hatanaka, T.; Nakagawa, R.; Fukuda, Y.; Morinaga, Y.; Suga, Y.; Nihei, Y.; Ohishi, K.; Akiyama, Y.; Tsuji T. Synthesis and antitumor activities of amino acid prodrugs of aminocombretastatins. Anti-Cancer Drug Des., 1999, 14(6), 539-548. (Pubitemid 30258972)
6. Young, S. L.; Chaplin, D. J. Combretastatin A4 phosphate: background and current clinical status. Expert Opin. Investig Drugs, 2004, 13(9), 1171-1182. (Pubitemid 39242740)
7. Banerjee, S.; Wang, Z.; Mohammad, M.; Sarkar, F. H.; Mohammad, R. M. Efficacy of selected natural products as therapeutic agents against cancer. J. Nat. Prod., 2008, 71(3), 492-496. (Pubitemid 351549382)
8. Maya, A. B.; del Rey, B.; Lamamie, de Clairac, R. P.; Caballero, E.; Barasoain, I.; Andreu, J. M.; Medarde, M. Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4. Bioorg. Med. Chem. Lett., 2000, 10(22), 2549-2551.
9. Pinney, K. G.; Mejia, M. P.; Villalobos, V. M.; Rosenquist, B. E.; Pettit, G. R.; Verdier-Pinard, P.; Hamel, E. Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin. Bioorg. Med. Chem., 2000, 8(10), 2417-2425.
10. Lawrence, N. J.; Hepworth, L. A.; Rennison, D.; McGown, A. T.; Hadfield, J. A. Synthesis and anticancer activity of fluorinated analogues of combretastatin A-4. J. Fluor. Chem., 2003, 123(1), 101-108.
11. Hadimani, M. B.; Hua, J.; Jonklaas, M. D.; Kessler, R. J.; Sheng, Y.; Olivares, A.; Tanpure, R. P.; Weiser, A.; Zhang, J.; Edvardsen, K.; Kane, R. R.; Pinney, K. G. Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4. Bioorg. Med. Chem. Lett., 2003, 13(9), 1505-1508. (Pubitemid 36428547)
12. Pérez-Melero, C.; Maya, A. B.; del Rey, B.; Peláez, R.; Caballero, E.; Medarde, M. A new family of quinoline and quinoxaline analogues of combretastatins. Bioorg. Med. Chem. Lett., 2004, 14(14), 3771-3774. (Pubitemid 38760078)
13. Kong, Y.; Grembecka, J.; Edler, M. C.; Hamel, E.; Mooberry, S. L.; Sabat, M.; Rieger, J.; Brown, M. L. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. Chem. Biol., 2005, 12(9), 1007-1014. (Pubitemid 41338811)
14. Coggiola, B.; Pagliai, F.; Allegrone, G.; Genazzani, A. A.; Tron, G. C. Synthesis and biological activity of mustard derivatives of combretastatins. Bioorg. Med. Chem. Lett., 2005, 15(15), 3551-3554. (Pubitemid 40942053)
15. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettit, R. K. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)-and (E)-combretastatin A-41. J. Med. Chem., 2005, 48(12), 4087-4099. (Pubitemid 40800617)
16. Nakamura, H.; Kuroda, H.; Saito, H.; Suzuki, R.; Yamori, T.; Maruyama, K.; Haga, T. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors. ChemMedChem, 2006, 1(7), 729-740. (Pubitemid 44154363)
17. Monk, K. A.; Siles, R.; Hadimani, M. B.; Mugabe, B. E.; Ackley, J. F.; Studerus, S. W.; Edvardsen, K.; Trawick, M. L.; Garner, C. M.; Rhodes, M. R.; Pettit, G. R.; Pinney, K. G. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents. Bioorg. Med. Chem., 2006, 14(9), 3231-3244.
18. Simoni, D.; Romagnoli, R.; Baruchello, R.; Rondanin, R.; Rizzi, M.; Pavani, M. G.; Alloatti, D.; Giannini, G.; Marcellini, M.; Riccioni, T.; Castorina, M.; Guglielmi, M.; Bucci, F.; Carminati, P.; Pisano, C. Novel combretastatin analogues endowed with antitumor activity. J. Med. Chem., 2006, 49(11), 3143-3152. (Pubitemid 43830513)
19. Fortin, S.; Moreau, E.; Lacroix, J.; Teulade, J. C.; Patenaude, A.; C-Gaudreault, R. N-Phenyl-N'-(2-chloroethyl) urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl) urea pharmacophore mimicking the trimethoxy phenyl moiety. Bioorg. Med. Chem. Lett., 2007, 17(7), 2000-2004. (Pubitemid 46389583)
20. Hall, J. J.; Sriram, M.; Strecker, T. E.; Tidmore, J. K.; Jelinek, C. J.; Kumar, G. D.; Hadimani, M. B.; Pettit, G. R.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4. Bioorg. Med. Chem. Lett., 2008, 18(18), 5146-5149.
21. Simoni, D.; Romagnoli, R.; Baruchello, R.; Rondanin, R.; Grisolia, G.; Eleopra, M.; Rizzi, M.; Tolomeo, M.; Giannini, G.; Alloatti, D.; Castorina, M.; Marcellini, M.; Pisano, C. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. J. Med. Chem., 2008, 51(19), 6211-6215.
22. Das, B. C.; Mahalingam, S. M.; Evans, T. Design and synthesis of novel pinacolylboronate containing combretastatin 'antimitotic agent' analogues. Tetrahedron Lett., 2009, 50(25), 3031-3034.
23. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J. Med. Chem., 1991, 34(8), 2579-2588.
24. Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Hatanaka, T.; Morinaga, Y.; Nihei, Y.; Ohishi, K.; Suga, Y.; Akiyama, Y.; Tsuji, T. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. J. Med. Chem., 1998, 41(16), 3022-3032. (Pubitemid 28359938)
25. Shirai, R.; Takayama, H.; Nishikawa, A.; Koiso, Y.; Hashimoto, Y. Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. Bioorg. Med. Chem. Lett., 1998, 8(15), 1997-2000. (Pubitemid 28372477)
26. Pettit, G. R.; Toki, B. E.; Herald, D. L.; Boyd, M. R.; Hamel, E.; Pettit, R. K.; Chapuis, J. C. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4. J. Med. Chem., 1999, 42(8), 1459-1465. (Pubitemid 29200882)
27. Flynn, B. L.; Flynn, G. P.; Hamel, E.; Jung, M. K. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg. Med. Chem. Lett., 2001, 11(17), 2341-2343. (Pubitemid 32781695)
28. Gwaltney, S. L. 2nd; Imade, H. M.; Barr, K. J.; Li, Q.; Gehrke, L.; Credo, R. B.; Warner, R. B.; Lee, J. Y.; Kovar, P.; Wang, J.; Nukkala, M. A.; Zielinski, N. A.; Frost, D.; Ng, S. C.; Sham, H. L. Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents. Bioorg. Med. Chem. Lett., 2001, 11(7), 871-874. (Pubitemid 32226204)
29. Lawrence, N. J.; Rennison, D.; Woo, M.; McGown, A. T.; Hadfield, J. A. Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers. Bioorg. Med. Chem. Lett., 2001, 11(1), 51-54. (Pubitemid 32006122)
30. Li, Q.; Woods, K. W.; Claiborne, A.; Gwaltney, S. L. 2nd; Barr, K. J.; Liu, G.; Gehrke, L.; Credo, R. B.; Hui, Y. H.; Lee, J.; Warner, R. B.; Kovar, P.; Nukkala, M. A.; Zielinski, N. A.; Tahir, S. K.; Fitzgerald, M.; Kim, K. H.; Marsh, K.; Frost, D.; Ng, S. C.; Rosenberg, S.; Sham, H. L. Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent. Bioorg. Med. Chem. Lett., 2002, 12(3), 465-469. (Pubitemid 34113926)
31. Wang, L.; Woods, K. W.; Li, Q.; Barr, K. J.; McCroskey, R. W.; Hannick, S. M.; Gherke, L.; Credo, R. B.; Hui, Y. H.; Marsh, K.; Warner, R.; Lee, J. Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S. H.; Sham, H. L. Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. J. Med. Chem., 2002, 45(8), 1697-1711. (Pubitemid 34293536)
32. Bailly, C.; Bal, C.; Barbier, P.; Combes, S.; Finet, J. P.; Hildebrand, M. P.; Peyrot, V.; Wattez, N. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. J. Med. Chem., 2003, 46(25), 5437-5444. (Pubitemid 37490376)
33. Liou, J. P.; Chang, J. Y.; Chang, C. W.; Chang, C. Y.; Mahindroo, N.; Kuo, F. M.; Hsieh, H. P. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents. J. Med. Chem., 2004, 47(11), 2897-2905. (Pubitemid 38656743)
34. Liou, J. P.; Chang, Y. L.; Kuo, F. M.; Chang, C. W.; Tseng, H. Y.; Wang, C. C.; Yang, Y. N.; Chang, J. Y.; Lee, S. J.; Hsieh, H. P. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J. Med. Chem., 2004, 47(17), 4247-4257.
35. Sun, L.; Vasilevich, N. I.; Fuselier, J. A.; Hocart, S. J.; Coy, D. H. Examination of the 1, 4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. Bioorg. Med. Chem. Lett., 2004, 14(9), 2041-2046. (Pubitemid 38481357)
36. Mateo, C.; Pérez-Melero, C.; Peláez, R.; Medarde, M. Stilbenophane analogues of deoxycombretastatin A-4. J. Org Chem., 2005, 70(16), 6544-6547. (Pubitemid 41076550)
37. Borrel, C.; Thoret, S.; Cachet, X.; Guénard, D.; Tillequin, F.; Koch, M.; Michel, S. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation. Bioorg. Med. Chem., 2005, 13(11), 3853-3864. (Pubitemid 40615935)
38. LeBlanc, R.; Dickson, J.; Brown, T.; Stewart, M.; Pati, H. N.; Van Derveer, D.; Arman, H.; Harris, J.; Pennington, W.; Holt, H. L. Jr.; Lee, M. Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins. Bioorg. Med. Chem., 2005, 13(21), 6025-6034. (Pubitemid 41399913)
39. Li, P. K.; Xiao, Z.; Hu, Z.; Pandit, B.; Sun, Y.; Sackett, D. L.; Werbovetz, K.; Lewis, A.; Johnsamuel, J. Conformationally restricted analogs of Combretastatin A-4 derived from SU5416. Bioorg. Med. Chem. Lett., 2005, 15(24), 5382-5385. (Pubitemid 41562954)
40. Tron, G. C.; Pagliai, F.; Del, Grosso, E.; Genazzani, A. A.; Sorba, G. Synthesis and cytotoxic evaluation of combretafurazans. J. Med. Chem., 2005, 48(9), 3260-3268. (Pubitemid 40628046)
41. Lawrence, N. J.; Armitage, E. S. M.; Greedy, B.; Cook, D.; Ducki, S.; McGown, A. T. The synthesis of indanones related to combretastatin A-4 via microwave-assisted Nazarov cyclization of chalcones. Tetrahedron Lett., 2006, 47(10), 1637-1640. (Pubitemid 43187968)
42. Bellina, F.; Cauteruccio, S.; Monti, S.; Rossi, R. Novel imidazolebased combretastation A-4 analogues: evalution their in vitro antitumor activity and molecular modelling study of their binding to the colochicine site of tubulin. Bioorg. Med. Chem Lett., 2006, 16, 5757.
43. Kaffy, J.; Pontikis, R.; Carrez, D.; Croisy, A.; Monneret, C.; Florent, J. C. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. Bioorg. Med. Chem., 2006, 14(12), 4067-4077.
44. Dupeyre, G.; Chabot, G. G.; Thoret, S.; Cachet, X.; Seguin, J.; Guénard, D.; Tillequin, F.; Scherman, D.; Koch, M.; Michel, S. Synthesis and biological evaluation of (3, 4, 5-trimethoxyphenyl) indol-3-ylmethane derivatives as potential antivascular agents. Bioorg. Med. Chem., 2006, 14(13), 4410-4426. (Pubitemid 43728664)
45. Banwell, M. G.; Hamel, E.; Hockless, D. C.; Verdier-Pinard, P.; Willis, A. C.; Wong, D. J. 4, 5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids: synthesis and evaluation as anti-mitotic and cytotoxic agents. Bioorg. Med. Chem., 2006, 14(13), 4627-4638. (Pubitemid 43744414)
46. Pandit, B.; Sun, Y.; Chen, P.; Sackett, D. L.; Hu, Z.; Rich, W.; Li, C.; Lewis, A.; Schaefer, K.; Li, P. K. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. Bioorg. Med. Chem., 2006, 14(19), 6492-6501. (Pubitemid 44233323)
47. De Martino, G.; Edler, M. C.; La, Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies. J. Med. Chem., 2006, 49(3), 947-954. (Pubitemid 43221643)
48. Peifer, C.; Stoiber, T.; Unger, E.; Totzke, F.; Schächtele, C.; Marmé, D.; Brenk, R.; Klebe, G.; Schollmeyer, D.; Dannhardt, G. Design, synthesis, and biological evaluation of 3, 4-diarylmaleimides as angiogenesis inhibitors. J. Med. Chem., 2006, 49(4), 1271-1281. (Pubitemid 43273496)
49. Romagnoli, R.; Baraldi, P. G.; Pavani, M. G.; Tabrizi, M. A.; Preti, D.; Fruttarolo, F.; Piccagli, L.; Jung, M. K.; Hamel, E.; Borgatti, M.; Gambari, R. Synthesis and biological evaluation of 2-amino-3-(3', 4', 5'-trimethoxybenzoyl)- 5-aryl thiophenes as a new class of potent antitubulin agents. J. Med. Chem., 2006, 49(13), 3906-3915. (Pubitemid 43967887)
50. Pirali, T.; Busacca, S.; Beltrami, L.; Imovilli, D.; Pagliai, F.; Miglio, G.; Massarotti, A.; Verotta, L.; Tron, G. C.; Sorba, G.; Genazzani, A. A. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents. J. Med. Chem., 2006, 49(17), 5372-5376. (Pubitemid 44260231)
51. Wu, M.; Sun, Q.; Yang, C.; Chen, D.; Ding, J.; Chen, Y.; Lin, L.; Xie, Y. Synthesis and activity of Combretastatin A-4 analogues: 1, 2, 3-thiadiazoles as potent antitumor agents. Bioorg. Med. Chem. Lett., 2007, 17(4), 869-873. (Pubitemid 46177634)
52. Sun, C. M.; Lin, L. G.; Yu, H. J.; Cheng, C. Y.; Tsai, Y. C.; Chu, C. W.; Din, Y. H.; Chau, Y. P.; Don, M. J. Synthesis and cytotoxic activities of 4, 5-diarylisoxazoles. Bioorg. Med. Chem. Lett., 2007, 17(4), 1078-1081.
53. Zhang, Q.; Peng, Y.; Wang, X. I.; Keenan, S. M.; Arora, S.; Welsh, W. J. Highly potent triazole-based tubulin polymerization inhibitors. J. Med. Chem., 2007, 50(4), 749-754. (Pubitemid 46332987)
54. Gurjar, M. K.; Wakharkar, R. D.; Singh, A. T.; Jaggi, M.; Borate, H. B.; Shinde, P. D.; Verma, R.; Rajendran, P.; Dutt, S.; Singh, G.; Sanna, V. K.; Singh, M. K.; Srivastava, S. K.; Mahajan, V. A.; Jadhav, V. H.; Dutta, K.; Krishnan, K.; Chaudhary, A.; Agarwal, S. K.; Mukherjee, R.; Burman, A. C. Synthesis and evaluation of 4/5-hydroxy-2, 3-diaryl (substituted)-cyclopent-2- en-1-ones as cisrestricted analogues of combretastatin A-4 as novel anticancer agents. J. Med. Chem., 2007, 50(8), 1744-1753. (Pubitemid 46626586)
55. La, Regina, G.; Edler, M. C.; Brancale, A.; Kandil, S.; Coluccia, A.; Piscitelli, F.; Hamel, E.; De, Martino, G.; Matesanz, R.; Díaz, J. F.; Scovassi, A. I.; Prosperi, E.; Lavecchia, A.; Novellino, E.; Artico, M.; Silvestri, R. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies. J. Med. Chem., 2007, 50(12), 2865-2874. (Pubitemid 46980857)
56. Mousset, C.; Giraud, A.; Provot, O.; Hamze, A.; Bignon, J.; Liu, J. M.; Thoret, S.; Dubois, J.; Brion, J. D.; Alami, M. Synthesis and antitumor activity of benzils related to combretastatin A-4. Bioorg. Med. Chem. Lett., 2008, 18(11), 3266-3271. (Pubitemid 351728092)
57. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cruz-Lopez, O.; Cara, C. L.; Tolomeo, M.; Grimaudo, S.; Di, Cristina, A.; Pipitone, M. R.; Balzarini, J.; Kandil, S.; Brancale, A.; Sarkar, T.; Hamel, E. Synthesis and biological evaluation of 2-amino-3-(3', 4', 5'-trimethoxybenzoyl)-6-substituted-4, 5, 6, 7-tetrahydrothieno[2, 3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization. Bioorg. Med. Chem. Lett., 2008, 18(18), 5041-5045.
58. Cafici, L.; Pirali, T.; Condorelli, F.; Del, Grosso, E.; Massarotti, A.; Sorba, G.; Canonico, P. L.; Tron, G. C.; Genazzani, A. A. Solutionphase parallel synthesis and biological evaluation of combretatriazoles. J. Comb. Chem., 2008, 10(5), 732-740.
59. Lee, L.; Davis, R.; Vanderham, J.; Hills, P.; Mackay, H.; Brown, T.; Mooberry, S. L.; Lee, M. 1, 2, 3, 4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4. Eur. J. Med. Chem., 2008, 43(9), 2011-2015.
60. Odlo, K.; Hentzen, J.; dit, Chabert, J. F.; Ducki, S.; Gani, O. A.; Sylte, I.; Skrede, M.; Flørenes, V. A.; Hansen, T. V. 1, 5-Disubstituted 1, 2, 3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorg. Med. Chem., 2008, 16(9), 4829-4838. (Pubitemid 351625899)
61. Xue, N.; Yang, X.; Wu, R.; Chen, J.; He, Q.; Yang, B.; Lu, X.; Hu, Y. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents. Bioorg. Med. Chem., 2008, 16(5), 2550-2557. (Pubitemid 351380926)
62. Romagnoli, R.; Baraldi, P. G.; Sarkar, T.; Carrion, M. D.; Cruz-Lopez, O.; Lopez-Cara, C.; Tolomeo, M.; Grimaudo, S.; Di-Cristina, A.; Pipitone, M. R.; Balzarini, J.; Gambari, R.; Ilaria, L.; Saletti, R.; Brancale, A.; Hamel, E. Synthesis and biological evaluation of 2-(3', 4', 5'-trimethoxybenzoyl)-3-N, N-dimethylamino benzo [b]furan derivatives as inhibitors of tubulin polymerization. Bioorg. Med. Chem., 2008, 16(18), 8419-8426.
63. Ty, N.; Dupeyre, G.; Chabot, G. G.; Seguin, J.; Tillequin, F.; Scherman, D.; Michel, S.; Cachet, X. Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3', 4', 5'-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents. Bioorg. Med. Chem., 2008, 16(15), 7494-7503.
64. Sriram, M.; Hall, J. J.; Grohmann, N. C.; Strecker, T. E.; Wootton, T.; Franken, A.; Trawick, M. L.; Pinney, K. G. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy. Bioorg. Med. Chem., 2008, 16(17), 8161-8171.
65. Ganina, O. G.; Daras, E.; Bourgarel-Rey, V.; Peyrot, V.; Andresyuk, A. N.; Finet, J. P.; Fedorov, A. Y.; Beletskaya, I. P.; Combes, S. Synthesis and biological evaluation of polymethoxylated 4-heteroarylcoumarins as tubulin assembly inhibitor. Bioorg. Med. Chem., 2008, 16(19), 8806-8812.
66. Liou, J. P.; Wu, Z. Y.; Kuo, C. C.; Chang, C. Y.; Lu, P. Y.; Chen, C. M.; Hsieh, H. P.; Chang, J. Y. Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors. J. Med. Chem., 2008, 51(14), 4351-4255.
67. Barbosa, E. G.; Bega, L. A.; Beatriz, A.; Sarkar, T.; Hamel, E.; do-Amaral, M. S.; de-Lima, D. P. A diaryl sulfide, sulfoxide, and sulfone bearing structural similarities to combretastatin A-4. Eur. J. Med. Chem., 2009, 44(6), 2685-2688.
68. Tanpure, R. P.; Harkrider, A. R.; Strecker, T. E.; Hamel, E.; Trawick, M. L.; Pinney, K. G. Application of the McMurry coupling reaction in the synthesis of tri-and tetra-arylethylene analogues as potential cancer chemotherapeutic agents. Bioorg. Med. Chem., 2009, 17(19), 6993-7001.
69. Alvarez, R.; Alvarez, C.; Mollinedo, F.; Sierra, B. G.; Medarde, M.; Peláez, R. Isocombretastatins A: 1, 1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds. Bioorg. Med. Chem., 2009, 17(17), 6422-6431.
70. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cara, C. L.; Cruz-Lopez, O.; Tolomeo, M.; Grimaudo, S.; Di-Cristina, A.; Pipitone, M. R.; Balzarini, J.; Zonta, N.; Brancale, A.; Hamel, E. Design, synthesis and structure-activity relationship of 2-(3', 4', 5'-trimethoxybenzoyl)-benzo [b]furan derivatives as a novel class of inhibitors of tubulin polymerization. Bioorg. Med. Chem., 2009, 17(19), 6862-6871.
71. Wu, Y. S.; Coumar, M. S.; Chang, J. Y.; Sun, H. Y.; Kuo, F. M.; Kuo, C. C.; Chen, Y. J.; Chang, C. Y.; Hsiao, C. L.; Liou, J. P.; Chen, C. P.; Yao, H. T.; Chiang, Y. K.; Tan, U. K.; Chen, C. T.; Chu, C. Y.; Wu, S. Y.; Yeh, T. K.; Lin, C. Y.; Hsieh, H. P. Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach. J. Med. Chem., 2009, 52(15), 4941-4945.
72. Shen, L.; Yang, X.; Yang, B.; He, Q.; Hu, Y. Novel hybrids from lamellarin D and combretastatin A 4 as cytotoxic agents. Eur. J. Med. Chem., 2010, 45(1), 11-18.